(April 9th, 2026) Webinar: Driving NAMs-Aligned Preclinical Research with the Newton 7.0 Optical Imaging Systems
(April 9th, 2026) Webinar: Driving NAMs-Aligned Preclinical Research with the Newton 7.0 Optical
Dr Krista Rantanen has an extensive academic career in the field of cancer research, specifically focusing on oxygen sensing mechanisms. She did her PhD on prolyl hydroxylase function in cancer and subsequently she’s been a part of starting a biomedical engineering company and did her postdoctoral period studying kidney cancer.
In 2018 she joined the Baker Company (USA) as their Director of Scientific Applications and has pursued in this global role since. 2022 she was also invited to be a Visiting Scientist in the research group of Nobel Laureate Sir Peter Ratcliffe at the Francis Crick Institute in London UK. There she continues her research on oxygen sensing mechanisms.
Dr Rantanen is also the lead of the global science for science initiative HypoxEU, the society for oxygen biology research supporting the work of thousands of scientists in the field.
(April 9th, 2026) Webinar: Driving NAMs-Aligned Preclinical Research with the Newton 7.0 Optical
(March 12, 2026) Webinar: Preclinical Imaging of Multiple Myeloma Bone Disease by Dual-Energy
(February 25, 2026) Webinar: How to Optimize Your Western Blot Workflow and Choose
(February 12, 2026) Webinar: Sharper Images, Stronger Studies- Optimizing Your Preclinical Ultrasound Techniques
(July 2, 2025) The World’s Smallest Pacemaker: Design and Applications Minimally Invasive. Wireless.
(June 12, 2025) From Scan to Results in Minutes: A Live Demo of